Bench to Bedside: From the Science to the Practice of Addiction Medicine
|
|
- Jennifer Matthews
- 6 years ago
- Views:
Transcription
1 Bench to Bedside: From the Science to the Practice of Addiction Medicine Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School ADDICTION MEDICINE ACADEMY Clearwater Beach, Florida March 26, 2015
2 Outline 1. The Neurobiology of Addiction 2. Psychosocial Treatments 3. Pharmacological Treatments 4. Conclusions 2
3 1 Neurobiology of Addiction 3
4 ~
5 The Fundamental Model Biological Psychological Addiction Social Use Brain Switch 5 Olsen and Levounis, Sober Siblings, 2008.
6 2015 6
7 Three Novel Areas 1. Continuum of Illness 2. Motivational Circuitry 3. Antireward Pathways 7
8 Reward Systems GAME 1? A. A sure gain of $250. B. 25% chance to gain $1,000, 75% chance to gain nothing. Adapted from: Tversky and Kahneman, Science,
9 Reward Systems GAME 1? A. A sure gain of $ % B. 25% chance to gain $1,000, 16% 75% chance to gain nothing. Adapted from: Tversky and Kahneman, Science,
10 Antireward Systems GAME 2? A. A sure loss of $750. B. 25% chance to lose nothing, 75% chance to lose $1,000. Adapted from: Tversky and Kahneman, Science,
11 Antireward Systems GAME 2? A. A sure loss of $ % B. 25% chance to lose nothing, 87% 75% chance to lose $1,000. Adapted from: Tversky and Kahneman, Science,
12 MATHEMATICS GAME 1 25% % % % GAME 2 25% % % %
13 HUMAN NATURE People avoid risks to ensure gains (even small gains). People take risks (even big risks) to avoid definite losses. Psychology trumps probability. 13
14 2 Psychosocial Treatments 14
15 1 st Wave: Psychoanalysis 1. Psychoanalysis works for all treatable mental illness. 2. Psychoanalysis does not work for addiction. 3. Therefore, addiction cannot be treated. 15
16 2 nd Wave: Boot Camps The prototype, Synanon, was founded in California in 1958 to address heroin addiction. The goal was to: Ø break down defenses, Ø bust through denial, and Ø reshape the addict s personality. 16
17 The Frying Pan 17 Volkow et al, J Neuroscience, 2001
18 3 rd : The Kitchen Sink Approach 1. Mutual Help Groups (12-step) 2. Cognitive Behavioral Therapy 3. Family Therapy 4. Primary Care Services 5. Mental Health Services 6. Aftercare Nunes, Selzer, Levounis, Davies, Substance Dependence and Co-Occurring Psychiatric Disorders,
19 Mutual Help 19
20 Attitudes and Perceptions MEDICAL STAFF 1. Housing 2. Gov t Services 3. Medical Services 4. Outpatient Tx 5. Job 6. Community 7. Trusting People 8. Inner peace 9. God 10. Spirituality 11. AA PATIENTS 1. Inner peace 2. God 3. Medical Services 4. AA 5. Housing 6. Spirituality 7. Outpatient Tx 8. Community 9. Gov t Services 10. Trusting People 11. Job What Medicine Thinks Patients Think 1. Housing 2. Outpatient Tx 3. Medical Services 4. Job 5. Trusting People 6. AA 7. Inner Peace 8. Community 9. Gov t Services 10. Spirituality 11. God 20 Goldfarb, Am J Drug Alcohol Abuse, 1996.
21 4 th : Motivational Interviewing (MI) Levounis and Arnaout, Handbook of Motivation and Change: A Practical Guide for Clinicians, Graphic by Lukas Hassel. 21
22 5 th : Mentalization Between stimulus and response there is a space. In that space is our power to choose our response. In our response lie our growth and our freedom. Viktor E. Frankl Frankl V, Man s Search for Meaning,
23 23
24 And Back to Psychodynamics % reporting any substance use disorders Only same-sex Mostly same-sex Equally both sexes Mostly other sex Only other sex * 11.4 *** * 9.6 *** 13.2 Ref Women Men *p<0.05, ***p<.001 based on logistic regression analysis adjusted for race, age, educational level, personal income, employment status, relationship status, health insurance status, geographic location, MSA, age at alcohol onset, and family history of AOD problems. Reference group was heterosexual group. 24 Courtesy of Sean McCabe, PhD.
25 3 Pharmacological Treatments 25
26 The Prescription Opioids Epidemic: The Root of the Disaster 26 Porter and Jick, N Engl J Med, January 10, 1980.
27 Chronic Non-Cancer Pain 27
28 Admissions: 1999 Primary non-heroin opioid admission rates (per 100,000) 28
29 Admissions: 2001 Primary non-heroin opioid admission rates (per 100,000) 29
30 Admissions: 2003 Primary non-heroin opioid admission rates (per 100,000) 30
31 Admissions: 2005 Primary non-heroin opioid admission rates (per 100,000) 31
32 Admissions: 2007 Primary non-heroin opioid admission rates (per 100,000) 32
33 Admissions: 2009 Primary non-heroin opioid admission rates (per 100,000) 33
34 Unintentional Drug Poisoning Deaths United States: Death rate per 100, Heroin Cocaine 1 0 Year '70 '72 '74 '76 '78 '80 '82 '84 '86 '88 '90 '92 '94 '96 '98 '00 '02 '04 '06 National Vital Statistics System, 34
35 Unintentional Drug Poisoning Deaths United States: Alcorn, The Lancet, June 5,
36 Addiction Strategies Ø Agonists: Methadone Nicotine Replacement Ø Partial Agonists: Buprenorphine Varenicline Ø Antagonists: Naltrexone Levounis and Herron, The Addiction Casebook,
37 The Ceiling Effect 100 % Efficacy Full Agonist (Methadone) Partial Agonist (Buprenorphine) Antagonist (Naloxone) Log Dose of Opioid Adapted from: Renner and Levounis, Office-Based Buprenorphine Treatment of Opioid Dependence,
38 4 Conclusions 38
39 1. Addiction hijacks the pleasure/reward and anti-reward pathways of the brain, as well as the person s internal motivation. 2. Cognitive Behavior Therapy, mutual help groups, and Motivational Interviewing revolutionized addiction treatment. 3. In 2015, buprenorphine is the first line treatment of opioid use disorder. 39
40 Thank you NJMS.Rutgers.edu/Psychiatry 40
Gambling Disorder as a Behavioral Addiction
Gambling Disorder as a Behavioral Addiction Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School New York Coalition for Asian American Mental Health NYS Office of Alcoholism
More informationMotivational Interviewing for Clinical Practice
Motivational Interviewing for Clinical Practice Petros Levounis, MD, MA, Rutgers New Jersey School of Medicine Bachaar Arnaout, MD, Yale School of Medicine Carla Marienfeld, MD, University of California,
More informationFundaments of Addiction Medicine. Addiction Medicine Express All of Addiction Medicine in 60 Slides and 60 minutes
1:15 2:3 pm Addiction Medicine Express SPEAKER Petros Levounis, MD, MA Presenter Disclosure Information The following relationships exist related to this presentation: Petros Levounis, MD, MA: No financial
More informationBuprenorphine and MAT 101
Buprenorphine and MAT 101 Why is Medication Assisted Treatment so Important for Recovery? KEN SAFFIER, MD 7 TH ANNUAL INTEGRATION SUMMIT DECEMBER 8, 2016 Disclosures: u Ken Saffier, MD, has nothing to
More informationAgenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model
Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationMedication-Assisted Treatment (MAT) Overview
Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for
More informationTHE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.
THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.
More informationConfronting the Opioid Epidemic: Suboxone in Primary Care
Confronting the Opioid Epidemic: Suboxone in Primary Care Kami Harless, MD 1 The Opioid Epidemic 2 The Opioid Epidemic 3 Washington Epidemic 4 King County Epidemic 5 King County Epidemic 6 Outline Opioid
More informationVivitrol/Suboxone. Comparison Study Summary
Vivitrol/Suboxone Comparison Study Summary Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., & King, J. (2017). Comparative effectiveness of extended-release naltrexone versus
More informationBuprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction
Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for
More information2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders
The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders Roger D. Weiss, MD Chief, Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA Professor of Psychiatry,
More informationMark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC
Opioid Use Disorders and Their Treatment Mark Edlund, MD, PhD RTI International Photo courtesy of The Herb Museum, Vancouver, BC Acknowledgements Funded by NIDA R01 DA022560-01 NIDA R01 DA034627 NIDA R01
More informationMedication Assisted Treatment of Substance Use Disorders
3 rd Annual Challenges & Innovations in Rural Psychiatry Conference Medication Assisted Treatment of Substance Use Disorders June 22, 2016 Medication Assisted Treatment of Substance Use Disorders Richard
More informationOpioid Use Disorder Treatment Initiation in Diverse Settings
Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures
More informationIt s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs
It s Not Just One More Thing! Overcoming Obstacles for Buprenorphine Treatment by Residents, Faculty and Programs Ken Saffier, MD Maureen Strohm, MD May 7, 2017 Disclosures Ken Saffier, MD, has nothing
More informationMass General s Substance Use Disorder Initiative
Mass General s Substance Use Disorder Initiative Martha Kane, PhD Sarah Wakeman, MD, FASAM Clinical and Medical Directors, Mass General Hospital Substance Use Disorder Initiative None Disclosures Objectives
More informationV. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS
V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS R esearch evidence supports the effectiveness of various substance abuse treatment approaches for adolescents. Examples of specific
More informationThe role of behavioral interventions in buprenorphine treatment of opioid use disorders
The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies
More informationThe Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016
The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of
More informationTHE STATE OF MEDICINE IN ADDICTION RECOVERY
OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,
More informationVivitrol Vs. Suboxone
Vivitrol Vs. Suboxone Vivitrol - Naltrexone Indicated for opiate dependence and alcohol withdrawal pure antagonist 380mg once every 4 weeks IM Peak plasma concentration in 2 hrs, followed by a second peak
More informationOpioid Overdose Epidemic A Crises and Opportunity
Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner
More informationNoel Schenk MD. Davis Behavioral Health
Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationAddiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer
Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South
More informationPennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story
Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric
More information6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder
Rethinking Medication Treatment for Opioid Use Disorder International Conference on Opioids June 10, 2018 Dustin Patil, MD Fellow, Addiction Psychiatry Boston Medical Center John Renner, MD Professor of
More information4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.
MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H. MEDICAL DIRECTOR, UNITYPOINT HEALTH MERITER/ NEWSTART ADJUNCT PROFESSOR, UNIVERSITY OF WISCONSIN MADISON
More informationBest Practice Workgroup Considerations. New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011
New Jersey Shared Values: Unified Child Welfare Practice Conference April 29, 2011 Evidence-based and Innovative Treatment Models: Setting the Stage for our Discussions Best Practice Workgroup Considerations
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationMaking Referrals. Welcome to the Recovery U module on making referrals.
Making Referrals Welcome to the Recovery U module on making referrals. By the end of this learning module, you ll be able to describe referral resource options for patients with substance use disorders,
More informationListen & Hear 4Lo
Mark Lim M.D FASAM Medical Director NorthLakes Community Clinic Recovery Program Board Certified in Family Medicine Board Certified in Addiction Medicine mlim@northlakesclinic.org 7156852200 Listen & Hear
More informationClose to Home A Recovery Brief WNC Recovery Recovery Ministries of the Episcopal Church
Close to Home A Recovery Brief WNC Recovery Recovery Ministries of the Episcopal Church Prayer for Victims of Addiction O blessed Lord, you ministered to all who came to you: Look with compassion upon
More informationShawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine
[Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com
More informationOpioid Dependence 101 and Medication Assisted Treatment
Opioid Dependence 101 and Medication Assisted Treatment Dr. Joji Suzuki Director of the Division of Addiction Psychiatry, Brigham & Women s Hospital Assistant Professor of Psychiatry, Harvard Medical School
More informationAcademic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD
Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop
More informationBuprenorphine as a Treatment Option for Opioid Use Disorder
Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital
More informationMedication Supported Recovery- A Review of Evidence-Based Practice
Medication Supported Recovery- A Review of Evidence-Based Practice Andrew B. Mendenhall, MD, DABAM, DABFM, Senior Medical Director, Substance Use Disorder Services, Central City Concern 1 Objectives 1.
More informationEnhanced Substance Abuse Management in Higher Risk Populations
Enhanced Substance Abuse Management in Higher Risk Populations Pano Yeracaris, MD, MPH Vice President & Chief Medical Officer, Network Health Annual Community Health Institute May 9-11, 2012 Resort & Conference
More informationSTIMULANTS. 1980s: Cocaine. Outline. General Roadmap
STIMULANTS Petros Levounis, MD, MA Chair, Department of Psychiatry Rutgers New Jersey Medical School Petros Levounis ASAM Disclosure of Relevant Financial Relationships Content of Activity: ASAM Review
More informationWhat are Substance Use Disorders?
What are Substance Use Disorders? Sanchit Maruti, MD Michael Goedde, MD University of Vermont Medical Center 1 Disclosures } Drs. Maruti and Goedde receive compensation as consultants to the American Academy
More informationArwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry
The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic
More informationOpioid Use Disorders &Medication Treatment
Agency medical director comments Opioid Use Disorders &Medication Treatment Charissa Fotinos, MD, MSc Deputy Chief Medical Officer Washington State Health Care Authority Learning Objectives: 1) Review
More informationCan 12 Step and Medications for Substance Use Disorders Co-Exist?
Can 12 Step and Medications for Substance Use Disorders Co-Exist? Laura G. Kehoe, MD, MPH Medical Director, Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Overview Brief overview
More informationOpiate Use Disorder and Opiate Overdose
Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5
More informationLESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC
LESSONS FROM THE PHYSICIAN HEALTH PROGRAM (PHP) EXPERIENCE FOR TODAY'S NATIONAL OPIOID EPIDEMIC Robert L. DuPont, M.D. President, Institute for Behavior and Health, Inc. 2 nd Annual Symposium on Addiction
More informationInjectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP
Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Overview Gavin Foundation Injectable naltrexone Community report
More informationDisclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond
Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to
More informationOpioid Use in Youth. Amy Yule M.D. March 2,
Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin
More informationAdvancing Addiction Science to Address the Opioid Crisis
Advancing Addiction Science to Address the Opioid Crisis National Institute on Drug Abuse Bringing the full power of science to bear on drug abuse and addiction Nora D. Volkow, M.D. Director National Institute
More informationNORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014
NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and
More informationBuprenorphine pharmacology
Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely
More informationDrug Addiction Is a Disease So What Do We Do about It?
Lesson 5 Elaborate/ Evaluate Drug Addiction Is a Disease So What Do We Do about It? Photo courtesy of Gray Wolf Ranch Wilderness Recovery Lodge. Overview Students make predictions about the success rate
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Institute for Behavioral Health Schneider Institutes
More informationMedications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC
Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are
More informationSUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic
SUBSTANCE ABUSE IN THE ELDERLY The Invisible Epidemic IS IT POSSIBLE TO TEACH AN OLD DOG NEW TRICKS? GUIDELINES All forms of addiction know no age limit. Don t blame all problems on aging. Few realize
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance
More informationMAT 101: TREATMENT OF OPIOID USE DISORDER
MAT 101: TREATMENT OF OPIOID USE DISORDER WITH SPECIAL EMPHASIS ON BUPRENORPHINE/NALOXONE ICADD May 22, 2018 Alicia Carrasco, MD Debby Woodall, LCSW, ACADC Magni Hamso, MD, MPH Terry Reilly Health Services
More informationThe Opiate Crisis. Presented by Dr. Anahi Ortiz Franklin County Coroner. October 24, 2018
The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner October 24, 2018 Why Words Matter Person First Language Person-first language is a philosophy of putting individuals before their
More informationOpiate Addiction: Treatment Perspectives
Opiate Addiction: Treatment Perspectives Daniel H. Angres M.D., Director, Positive Sobriety Institute Chief Medical Officer, RiverMend Health Addiction Services Adjunct Associate Professor of Psychiatry,
More information7/7/2016 Journal of the American Medical Association,
1 2 Journal of the American Medical Association, 2008 3 The Clinical Trial 152 Adolescents and Young Adults (Age 15 to 21) randomly assigned to either; 1. 2 weeks of Buprenorphine detox 2. 12 weeks of
More informationQUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.
2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted
More informationCharles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus
Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationOpioid Epidemic as it Relates to Counties
89 TH ANNUAL WEST TEXAS COUNTY JUDGES AND COMMISSIONERS ASSOCIATION CONFERENCE Wednesday, April 25, 2018 11:05 11:55 a.m. Opioid Epidemic as it Relates to Counties Ms. Jessica Cance Agency Analytics Unit
More informationOPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)
OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI) Case 105- Prep Materials University of Massachusetts Medical School Opioid Conscious Curriculum Learner Prep Objectives The purpose of this prep material
More informationSubstance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates
Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for Responsible
More informationNavigating the. Addiction. A Four-Letter Word!!! What is Addiction? Definition of Addiction: Definition of Addiction: (cont)
Navigating the Addiction of What is Addiction? Addiction is a slow, gradual, insidious, elusive becoming! Caroline Knapp Presented by: Thomas W. O Reilly, MS, PCC-S Lakeshore Educational & Counseling Services
More informationIntNSA Webinar Series
BUPRENORPHINE CLINIC: A MULTIDISCIPLINARY MODEL FOR OPIOID MAINTENANCE THERAPY Stephen Strobbe, PhD, RN, NP, PMHCNS-BC, CARN-AP Monday, June 4, 2012 IntNSA Webinar Series Funding for this webinar was made
More informationDivision of Mental Health and Addiction Services
Division of Mental Health and Addiction Services A DAM BUCON, LSW DMHAS Mission DMHAS, in partnership with consumers, family members, providers and other stakeholders, promotes wellness and recovery for
More informationSafe Practices and Action Items
Safe Practices and Action Items Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine Case Study A 58 year
More informationOpioids and Opioid Addiction: Practical Management Approaches
Opioids and Opioid Addiction: Practical Management Approaches Yngvild Olsen, MD, MPH Medical Director Institutes for Behavior Resources Inc/REACH Health Services Conflict of Interest No financial or advisory
More informationLA County, Medications for Addiction Treatment, and the Substance Use Care Continuum
LA County, Medications for Addiction Treatment, and the Substance Use Care Continuum Brian Hurley, M.D., M.B.A., DFASAM Medical Director of Substance Use Related Care Integration Los Angeles County Health
More informationHOUSE Calls. Addiction Medicine. Winter Published by the Alachua County Medical Society
HOUSE Calls Published by the Alachua County Medical Society Winter 2017 Addiction Medicine Addiction as a Disease Gregory L. Jones, MD, FASAM, FAAF, UF Health Florida Recovery Center Scott A. Teitelbaum,
More informationThe Opioid Crisis: What Can Physicians Do About It?
The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures
More informationOPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL
OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial
More informationCare in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities
Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationStriking a Balance: a provider perspective.
Striking a Balance: a provider perspective kpfeifer@chcf.org Beth s story 38 years old, erratically employed Counseling doesn t help Chronic low back pain after car accident 8 Vicodin/day grew to 180 mg
More informationOverview of Opioid Use Disorder
Overview of Opioid Use Disorder Doug Burgess, MD Medical Director of Outpatient Services, Truman Medical Centers Assistant Professor of Psychiatry, University of Missouri- Kansas City Objectives History
More information11/7/2016. Possession by evil spirits? Demon rum. Lack of moral fiber? War on drugs Just say no
Dean Drosnes, MD, FASAM Associate Medical Director Caron Treatment Centers ASAM Disclosure of Relevant Financial Relationships Date of Activity: Nov 3, 2016 Name Commercial Interests Relevant Financial
More informationMAT in the Corrections Setting
MEDICATION ASSISTED TREATMENT AND CORRECTIONS Frank Filippelli, DO, PhD September 2017 MAT in the Corrections Setting Who Does This Affect? What is MAT and What is the Evidence of Efficacy? Emphasis on
More informationMedication-Assisted Treatment (MAT) for Opioid Use Disorders
Medication-Assisted Treatment (MAT) for Opioid Use Disorders Sybil Marsh MA MD FASAM Department of Family Medicine and Community Health Case Western Reserve University/UHCMC Learning Objective 1 Following
More informationMedication Assisted Treatment
Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,
More informationThe available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines
The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs
More informationAppendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data
Data Supplement for Kennedy-Hendricks et al. (10.1176/appi.ps.201600056) Appendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data Un-weighted
More informationLGBT PERSPECTIVES IN ADDICTION MEDICINE
LGBT PERSPECTIVES IN ADDICTION MEDICINE Petros Levounis, MD, MA Director, The Addiction Institute of New York Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons
More informationKRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH
KRISANNA DEPPEN, MD FAMILY MEDICINE, ADDICTION MEDICINE GRANT MEDICAL CENTER-OHIOHEALTH COLUMBUS, OH IF THESE MOMS REALLY CARED ABOUT THEIR BABIES, THEY WOULD JUST QUIT Those who can quit, often do Addiction
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible Opioid Prescribing Senior Scientist, Heller School
More informationNeuroscience of Addiction
Neuroscience of Addiction Carlton Erickson, Ph.D. Associate Dean for Research and Graduate Studies Distinguished Professor of Pharmacology Director, Addiction Science Research and Education Center College
More information5/30/ New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services. Objectives
2018 New England Summer School Lindy S. Keller, M.S., MLADC - NH Bureau of Drug & Alcohol Services Objectives Describe the neurological basis of addiction Explain how addiction manifests in various aspects
More informationMedication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs
Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs
More informationTreatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History
Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic What should we do with this case? 17 M Onset prescription opioids 15, progressing to daily use with withdrawal within 8 months Onset
More information